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AIMS AND OBJECTIVES 
 
 
 
 
              To determine the utility of proximal to distal facial nerve amplitude and latency ratios in 
predicting postoperative facial nerve function in patients undergoing excision of vestibular 
schwannomas. 
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                                             INTRODUCTION 
 
 
            Acoustic tumors are benign neoplasms of Schwann cell origin that occur 
predominantly on the vestibular branches of the acoustic nerve (80%) and from the 
cochlear part in only about 5-7% (1).  The tumors variously known as acoustic 
neurinomas, acoustic neuromas, and vestibular schwannomas constitute an important 
intracranial pathology entity, accounting for 6 to 8% of all intracranial neoplasms and 80 
to 90% of tumors of cerebellopontine angle (2).  Since they arise from the superior 
division of the vestibular nerve and not from the acoustic division of the eight cranial 
nerve, and are composed of Schwann cells in the neurilemma, the more accurate term 
“vestibular schwannoma” has been proposed (4). The majority of acoustic schwannomas 
are sporadic and unilateral (3). Bilateral tumors are hereditary and constitute less 5% of 
all schwannomas (4). They present commonly in the fourth to sixth decade and it is a 
decade earlier in India (5, 6).                   
               The clinical presentation of acoustic neuromas can vary widely, but the earliest 
symptom is usually hearing loss. A history of progressive unilateral hearing loss, usually 
over many months and sometime years, is the hallmark of an acoustic neuroma. 
Compression of the facial nerve obviously occurs early, but the facial symptoms are rare 
in the early stages. When they do occur, fasciculation’s are the most common 
manifestation. 
       Anatomic and functional preservation of the facial nerve is a primary goal during 
microsurgical resection of vestibular schwannomas.  While the anatomic integrity of the 
facial nerve can be preserved in a majority of cases, this does not guarantee functional 
preservation (7).  A normal initial facial nerve examination after surgery strongly 
correlates with long term functional preservation of the facial nerve even in the setting of 
delayed weakness. Patients with immediate postoperative facial nerve weakness represent 
a small but important group that is at increased risk for a poor facial nerve outcome. The 
ability to predict recovery versus permanent dysfunction would be beneficial in 
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counseling patients as well as planning facial nerve rehabilitation. Intraoperative facial 
nerve monitoring has been shown to improve facial nerve outcome in multiple studies 
(8). Several intraoperative monitoring parameters have been used to predict functional 
facial nerve preservation.  In this study we assessed two independent intraoperative 
monitoring parameters:  proximal to distal facial nerve amplitude and latency ratios in 
predicting long term facial function.                  
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                                                REVIEW OF LITERATURE  
   
         The first presumptive case of vestibular schwannoma dates back to the second 
half of the 18th century.  As reported by Ahn, et al. (9), in 1777 Eduard Sandifort, 
described at autopsy the first unilateral acoustic tumor.  Several reports on tumors related 
to the auditory nerve followed, but it was not until 1830 that Charles Bell gave an 
accurate description of what appears to be a definitive case of acoustic tumor.  A few 
years later, Curveilhier published a detailed report on the progression of clinical 
symptoms and the postmortem findings in a patient. During the last decades of the 19th 
century, advances in the histological and pathological characterization of tumors led to a 
more solid correlation of a patient’s clinical symptoms with the actual diagnosis obtained 
at autopsy. Sternberg (1900) is credited with the first accurate pathological description of 
an acoustic neurinoma (10). 
            The first reported case of successful surgery in the cerebellopontine angle (in 
which patient survived) was performed in 1894 by a British surgeon, Sir Charles Balance 
(11).  In early part of this century most patients with vestibular shwannomas presented 
with very large tumors and significant brainstem compression. The aim of surgery was to 
decompress the posterior fossa and surgical mortality was 80%. In 1917 Cushing 
advocated subtotal resection of acoustic tumours and with improved surgical technique 
and haemostasis was able to lower perioperative mortality to 20% (12).  Dandy was the 
first American surgeon to perform total resection of acoustic tumors successfully and the 
first to describe the unilateral approach to the cerebellopontine angle. Because many 
patients at this time presented with facial palsy, postoperative facial nerve palsy was a 
uniform complication. This trend prevailed until the latter half of the last century; it is 
only in recent decades that emphasis has been placed on preservation of facial nerve 
function. 
              The achievements in vestibular schwannoma surgery were conspicuously 
marked by the following advances: 1) a better understanding of the microsurgical 
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anatomy; 2) the use of operating microscope; and 3) significant advances in 
neuroanaesthesia, neurophysiology, and in standard microsurgical techniques.  
          In 1931 Cairns was the first surgeon to document preserved facial nerve function. It 
was only until 1940, when Olivecrona employed an operating room nurse to observe 
facial twitching during tumor resection (12).  In 1961, William House pioneered a new 
era in acoustic surgery with introduction of the operating microscope.  He introduced the 
translabyrinthine and middle fossa approaches for removal of vestibular schwannoma 
tumours. In 1957, Theodore Kurze for the first time resected a vestibular schwannoma 
using an operating room microscope.  In 1965, Kurze and Rand (13) reported 
suboccipital transmeatal microdissection to remove vestibular schwannoma totally, 
affording the possibility of preservation of the facial and cochlear nerves. These 
approaches and refinement of the technique also led to an increased rate of facial nerve 
preservation during tumor resection.  
        Further refinements by M. Gazi Yasargil in the microsurgical techniques and 
instruments revolutionized vestibular schwannoma surgery.  He was influenced by the 
idea of Kurze and others to make microsurgery a fundamental part of modern 
neurosurgery (14).  
          Using his extensive experience in vestibular schwannoma surgery, Majid Samii has 
established landmark outcomes with respect to the preservation of facial and hearing 
functions (15, 16). 
          In the cerebellopontine angle, tumor growth distorts normal anatomic relationships, 
making neural identification difficult. Of all the surgeries that entail surgery near the 
facial nerve, resection of acoustic neuroma involves the highest risk of iatrogenic injury 
(17).  The intracranial facial nerve is more susceptible to injury because of the absence of 
fibrous epineural protective layer found peripherally. In addition, the facial is thinned, 
attenuated and displaced by acoustic neuromas in the mid cerebellopontine angle. This 
segment of facial nerve, medial to the porus acousticus in the cerebellopontine angle, is 
the site of most injuries. Even anatomical preservation of the facial nerve during 
cerebellopontine angle surgery does not ensure normal or even satisfactory function (18). 
          A variety of techniques are available for the electrodiagnosis 
of the pathologies of muscle, peripheral nerve,  and their central nervous system  
distribution.  Historically, the earliest investigations were performed in the late 18th 
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century by Galvani, who published his observations on electricity and muscle 
contraction.  In 1848, Dubois-Raymond discovered the action potential and described it 
as a negative variation of the standing potential of a nerve related to the conduction of a 
nerve impulse.  Soon thereafter, Hermann von Helmholtz recorded the conduction 
velocity in a median nerve in a human (19). 
  
HISTORY OF FACIAL NERVE MONITORING 
 
           In performing intracranial surgery that requires prolonged 
dissection and retraction of vital centers and cranial nerves, intraoperative  
electrophysiological monitoring is useful to the surgeon in localization as well as in 
assessing the extent of the manipulation of these structures. Cranial nerves two to twelve 
can be monitored by evoked response potentials (visual evoked potentials, BAEPs), 
triggered EMG, or a combination of the two. Except for cranial nerves two and eight, the 
remaining nerves can be monitored by compound muscle action potential (CMAP) 
triggered by manipulation or direct nerve stimulation.  The nerves most commonly 
monitored during vestibular schwannoma surgery are cranial nerves seven and eight.   
            In 1893, Krause noted that low-current electrical stimulation of the seventh 
cranial nerve produced contractions in the facial muscles during sectioning of the eighth 
cranial nerve for tinnitus.  Before 1960, a large percentage of patients who underwent 
vestibular schwannoma surgery had significant long term facial nerve dysfunction, 
House-Brackmann grade 3 or worse (20).  In 1970’s and early 1980’s, before the 
common use of intraoperative facial nerve monitoring (IOFNM), facial paralysis after 
acoustic neuroma surgery was still a significant issue.  By the early 1990’s, the 
advantages of IOFNM in cerebellopontine angle surgery were clear. 
         Historically, detection of facial nerve activity during surgery was possible by 
observation of facial muscle movement or by ingenious inventions such as suturing bells 
to the patients face and listening for a response.  J. David Williams in 1988 described a 
technique in which “jingle bells” were sutured in three positions on the face at the points 
of maximum excursion of the facial musculature when stimulated by a Hilger nerve 
stimulator set at 2 mA (21).  This procedure was used to monitor movement of the facial 
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nerve while surgeon dissects the nerve in the cerebellopontine angle and internal auditory 
canal. 
          To facilitate preservation of the facial nerve during resection of large acoustic 
neuromas, Delgado, et al, (22) in 1979 developed a modified system of intraoperative 
electromyography.  This method involved stimulation of the facial nerve with a probe 
during surgery.  Surface electrodes over the facial muscles detected the evoked responses 
and an oscilloscope was used to monitor the activity of the facial nerve. They 
photographed the EMG recordings for the purpose of detecting small changes that might 
occur during the operation and that would indicate deterioration of facial nerve function. 
        In 1982, Sugita and Kobayashi (23) monitored facial nerve function by positioning 
accelerometers over the facial muscles and transducing the output to an audiometry signal 
that could be heard by the surgeon.  For recognition of the facial muscle responses to 
stimulation, they used a newly designed facial monitor. Accelerometers weighing 3 gm 
were attached to the orbicularis oculi and oris muscles.  The facial movements were 
converted to sound by means of an accelerometer, amplifier, and speaker.  Thus the 
surgeon was thus able to recognise the facial responses without necessity of having the 
patient’s face observed under the drapes by an anesthesiologist or ancillary personnel. 
              Later in 1984, Moller and Jannetta (24) combined the audiometry feedback 
features with the use of EMG to develop a more sophisticated level of monitoring. In 
addition these investigators introduced monopolars, low impedence constant voltage 
stimulation to localize the facial nerve and assess its functional integrity.  The electrical 
activity (EMG responses) of the facial muscles were recorded from two needle electrodes 
(Grass Type E2 subcutaneous platinum needles), one placed in the orbicularis oris and 
the other in the orbicularis oculi.  The ground electrode was placed on the forehead. The 
potentials from these two electrodes are amplified differentially using a Grass P511J 
amplifier equipped with a current limiting probe.  The potentials were displayed on an 
oscilloscope, and wave made available through a loudspeaker using an audio-amplifier. 
Anatomy and Physiology of Nerve Conduction and  Electrophysiological basis 
of monitoring     
           
        The peripheral nerve trunk contains motor, sensory and autonomic axons, which 
may be myelinated or unmyelinated; the myelinated ones have a faster conduction 
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velocity. Conduction has two types: continuous or saltatory.  The former occurs in 
unmyelinated nerve fibers and is continuous and bidirectional.  Saltatory conduction 
occurs in  myelinated fibers.  When a mixed nerve is maximally stimulated and recorded 
monophasically, there is a somewhat irregular contour to the action potential based on the 
different velocities and thresholds of the nerve (this is called a “compound nerve action 
potential” CMAP). Following the fall of the electrical response in the action potential, 
there are two low amplitude, relatively low deflections, based on prior spike activity. The 
first is a negative after-potential. The nerve is still excitable at this point, and, in fact, may 
be more easily excitable. Following this, a positive after-potential occurs where the nerve 
has a high threshold to activation. Both states relate to Na+ permeability. A motor unit 
consists of a motor axon and the population of muscle fibers innervated. The 
neuromuscular junction is a synapse at which the neural impulse stimulates the release of 
acetylcholine from the axon terminals, resulting in a brief muscle contraction. The 
consequent electrical response is the CMAP (19) Fig. 1. 
 
              
Fig. 1 CMAP variables. CMAP = compound muscle action potential; vertical arrows 
= CMAP amplitude; horizontal arrows = CMAP duration; shaded phases = CMAP 
area. 
 16
           The technique of performing intraoperative electrophysiological monitoring of 
facial nerve is described in the methodology. 
 
FACIAL NERVE MONITORING AND POSTOPERATIVE FUNCTION 
  
               Prior to the use of intraoperative monitoring, the anatomical preservation rate 
of facial nerve ranged from 30-96.6% and the functional preservation rate ranged from 
20-77% in various studies (Table 1).   The premise of using intraoperative facial nerve 
monitoring in acoustic neuromas is that facial nerve outcome will be improved in the 
immediate and late postoperative period.  The facial nerve function following acoustic 
tumour surgery with the use of monitoring showed anatomical preservation rate of 80–
100% and the functional preservation rate from 53–100% in various studies (Table 2).    
 
                                               (Table 1) 
Facial Nerve Outcome Without Intraoperative Facial Nerve Monitoring 
S.NO Author/Year Year
Number 
of 
Patients 
Anatomical 
Preservation  
( % ) 
  Functional   
Preservation  
( % ) 
Total tumor 
Removal     
( % ) 
1 Alfredo & Olivecrona H, et al.,(25) 1949 300 30 20 72 
2 Hullay J, et al.,(26) 1965 50 64 36 96 
3 Charles G. Drake (27) 1967 30 48 26 90 
4 Herbert Olivecrona (28) 1967 282 39.4 10 100 
5 Ephraim I.Z, et al.,(29) 1979 120 54.2 45 100 
6 House W.F, et al.,(30) 1979 500 96.6 48 93.4 
7 King T.T & Morrison A.W (31) 1980 150 54 39 NA 
8 Richard H.L, et al., (32) 1982 33 83 45 84 
9 Glasscock M.E, et al., (33) 1986 616 82 NA 99 
10 Sterkers J.M & Bowdler DA (34) 1988 800 94 50 NA 
11 Tos M & Thomsen J (35) 1988 300 95 67 NA 
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12 Hardy D.G, et al.,(36) 1989 100 82 77 97 
13 V.K.Jain, et al., (74) 2005 259 79 39 96.5 
   NA - Not addressed  in article      
 
                                                  (Table 2) 
Facial Nerve Outcome With Intraoperative Facial Nerve Monitoring 
S.NO Author/Year Year 
Number 
of 
Patients
Anatomical 
Preservation  
( % ) 
  Functional   
Preservation  
( % ) 
Total tumor 
Removal     
( % ) 
1 Sugita K, et al.,(23)  1982 65 90 78 93 
2 Moller A.R, et al.,(24) 1984 10 100 100 NA 
3 Harner S.G. & Ebersold M.J,(5) 1985 160 81 75 98 
4 Benecke J.E, et al.,(37) 1987 18 100 94 94 
5 Richard L.P, et al.,(38) 1987 20 95 75 95 
6 Ryuzo S, et al.,(39) 1988 89 80 73 87 
7 Niparko J.K, et al.,(40) 1989 29 100 86 NA 
8 Hammerchlag P.E, et al.,(41) 1990 111 NA 82 NA 
9 Dickins John & Graham S,(42) 1991 41 NA 85 NA 
10 Ebersold M.J, et al.,(43) 1992 255 92.6 64 97 
11 Arriaga M.A, et al.,(44) 1993 515 NA 87 98.6 
12 Lalwani A.K, et al.,(45) 1994 129 99.2 90 77 
13 Briggs R.J.S, et al.,(46) 1994 167 92 NA NA 
14 Barbara A.E, et al.,(47) 1994 70 100 84 50 
15 Taha J.M, et al.,(48) 1995 20 100 65 100 
16 Samii M, et al.,(15) 1997 1000 93 70 97.9 
17 William B.G, et al.,(50) 1997 179 99.4 96 99 
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18 Prakash Sampath, et al., (12) 1997 611 97.5 89.7 99.5 
19 Todd H. Lanman, et al.,(51) 1999 190 94 53 96.3 
20 Morikawa M, et al.,(52) 2000 18 100 83 100 
21 Brandon Isaacson et al.,(53) 2003 229 100 87 NA 
22 Vincent D, et al.,(49) 2004 312 96 71 97.5 
23 Samii M, et al.,(54) 2006 200 98.5 81 98 
24 Abraham Jacob, et al.,(55) 2007 359 NA >90 (I-III) NA 
NA - Not addressed in article  
 
 
 
   
                Niparko, et al, (40) in 1989 for the first time reported the results of correlating 
proximal to distal amplitude ratios with facial nerve outcome in 29 patients who 
underwent translabyrinthine excision of the acoustic neuroma and were followed for one 
year.  Of these 29 cases, 24 demonstrated equal responses with proximal and distal 
stimulation (1:1) at the completion of the procedure. 16 of these 24 patients (67%) 
demonstrated normal facial function (House and Brackmann Grade I) 1week 
postoperatively.  One year postoperatively, 21 of these 24 patients (88%) had Grade I 
facial function. None of these 24 patients demonstrated complete postoperative facial 
paralysis.  Thus, equal distal-proximal evoked responses suggested a good prognosis for 
the eventual recovery.  4 out of the 29 cases demonstrated a reduced proximally evoked 
response.  In one of these 29 cases, proximal stimulation evoked no response.  Two of the 
four cases with a reduced proximal response demonstrated facial weakness (Grade III and 
V) 1 week postoperatively. One of these two cases regained normal facial function after 1 
year. The single case of absence of the proximally evoked response demonstrated 
complete paralysis (Grade VI) 1 week and 1 year postoperatively. Thus it was concluded 
that a reduced proximal response at the end of the procedure may indicate postoperative 
facial weakness. The mere presence of a response with proximal stimulation at the end of 
the procedure, however, indicates that the facial nerve is at least partially intact. 
However, the authors did not correlate the values of proximal to distal amplitude ratios 
with final facial nerve outcome and did not study the association between intraoperative 
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amplitude ratios, initial postoperative facial nerve function, and final facial nerve 
function. 
          Ebersold, et al., (43) in 1992 reported that proximal to distal amplitude ratios 
greater than 0.9 were associated with good initial and final postoperative facial nerve 
function; ratios between 0.5 and 0.9 were associated with significant initial postoperative 
facial nerve weakness but good final facial nerve function; ratios less than 0.5 were 
associated with poor initial facial nerve function and varying degrees of final facial nerve 
weakness. 
          Taha, et al, (48) in 1995 reported the first detailed analysis of the association 
between proximal to distal facial nerve amplitude ratios and initial and final postoperative 
facial nerve function. The facial nerve was stimulated using a monopolar stimulator 
probe with a constant current of 4 pulses per second for 100 msec. The stimulus was set 
at the lowest intensity required to elicit an EMG response, beginning at 0.05 mA and not 
exceeding 1 mA. The facial nerve was stimulated at the proximal and distal points after 
tumor excision. The response amplitudes were recorded in microvolts. Six readings were 
obtained: three from proximal and three from distal stimulation. The highest proximal to 
distal ratios were used to predict initial and final postoperative facial nerve function. 
They found that higher proximal to distal amplitude ratios were associated with better 
initial and final postoperative facial nerve function. All patients with ratios greater than 
2:3 had grade III or better initial postoperative facial nerve function and grade I final 
facial nerve function. 90% of patients with ratios between 1:3 and 2:3 had grade III or 
worse initial postoperative facial nerve function and all had grade III or better final 
postoperative facial nerve function. All patients with ratios less than 1:3 had grade IV or 
worse initial and final postoperative facial nerve function. However, the result of this 
study was inconclusive because the rates of facial nerve recovery in different patient 
groups overlapped and the number of patients (twenty) was too small. 
            Sobottka, et al, (56) in 1998 also evaluated amplitude ratios for a series of 40 
patients. They also evaluated proximal and distal absolute EMG amplitudes and 
stimulation threshold for prediction of initial postoperative nerve function and recovery 
of function. Good initial facial nerve outcome (modified House and Brackmann grading I 
& II) was found in 15/16 patients with a proximal EMG amplitude greater 800 microvolts 
and in 19/22 patients with proximal stimulation threshold of less than 0.3 mA. Sixteen of 
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16 patients with proximal stimulation threshold equal to or greater than 0.3 mA had 
moderate to severe facial palsy (HB III or worse). Six of six patients with without 
evokable proximal amplitude initially had poor facial nerve function (HB IV). A 
proximal amplitude of 300 microvolts or less and a proximal to distal amplitude ratio 
below 1: 3 were found in the absence of functional recovery in 6/8 (75%) and 5/6 (83%) 
patients with initial HB IV, respectively.  They concluded that absolute values of 
proximal amplitudes were more reliable predictors than proximal to distal ratios.  
              Goldbrunner RH, et al, (57) in 2000 did a quantitative  analysis  of  absolute 
values and ratios (proximal/distal) of evoked EMG parameters (amplitude, latency and 
duration) in 137 patients and were correlated with postoperative ( 1week,  6 weeks and 6 
months) facial nerve function. Absolute values of EMG amplitude and amplitude ratios  
(proximal/distal)  demonstrated a good predictive power. For EMG latencies, only the 
ratios revealed a significant correlation with facial nerve function. Latencies and latency 
ratios are also easily influenced by intraoperative maneuvers that lead to nerve edema and 
reversible nerve blocks. They found that an amplitude ratio of greater than or equal to 0.3 
had a good chance for facial nerve function recovery and in contrast, a ratio of less than 
0.1 had poor facial nerve function outcome.  Because absolute values of CMAP 
amplitudes are available at every phase during surgery, these are the most appropriate 
parameters for routine assessment of the status of the facial nerve during surgery.  So it 
was concluded that due to their lower predictive power, latency ratios should be used 
only as supplementary parameters and statements concerning expected facial nerve 
outcomes should be based on the amplitude ratios, which are the strongest predictors.  
             Isaacson et al, (53) in 2003 did a retrospective case review of 229 patients 
undergoing resection of vestibular schwannoma with intraoperative facial nerve 
monitoring at a single institution. They found that the proximal to distal amplitude ratio 
and proximal electric threshold were statistically significant in predicting facial nerve 
outcome. They concluded that use of   intraoperative facial nerve monitoring may be 
useful to predict poor long term outcomes and thus modify the timing of rehabilitation.      
               Various parameters have been studied during the facial nerve monitoring in 
acoustic nerve tumor and cerebellopontine angle surgeries. Table 3 shows the parameters 
which have been studied during facial nerve monitoring. 
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Table (3) 
VARIOUS PARAMETERS USED IN INTRAOPERATIVE FACIAL NERVE MONITORING 
SN Author/Year Year Amp of 
CMAP 
Latency 
of CMAP  
Prox to Dist 
ratio of 
CMAP Amp  
Prox to Dist 
ratio of 
CMAP Lat   
Duration 
of 
CMAP  
Dura 
tion of 
stim.  
Stim. 
threshold 
Prox. to 
Dist. ratio of 
stim. thres   
   F 
wave 
Train 
time  
Burst 
pattern 
Useful 
Parameters 
1 Prass R.L, et al.,(38) 1987 Yes         Yes Yes 1, 10, 11 
2 Ryuzo S, et al.,(39) 1988 Yes           1 
3 Niparko J.K, et al.,(40) 1989 Yes  Yes       Yes Yes 1, 3, 10, 11 
4 Hammerchlag, et al.,(41) 1990 Yes      Yes   Yes Yes 1, 7, 10, 11 
5 Dickins& Graham S (42) 1991 Yes         Yes Yes 1, 10, 11 
6 Beck D.L, et al.,(58) 1991 Yes      Yes     1, 7 
7 Prasad S, et al.,(59) 1993       Yes     7 
8 Lalwani A.K, et al.,(45) 1994       Yes     7 
9 Silverstein H, et al.,(60) 1994       Yes     7 
10 Taha J.M, et al.,(48) 1995 Yes  Yes    Yes     1, 3, 7 
11 Selesnick S.H, et al.,(61) 1996      Yes Yes     6, 7 
12 Hone S.W,et al.,(62) 1997       Yes   Yes Yes 7, 10, 11 
13 Sobottka S.B, et al.,(56) 1998 Yes  Yes    Yes     1, 3, 7 
14 Goldbrunner, et al.,(57) 2000 Yes Yes Yes Yes Yes Yes      1, 2, 3, 4, 6 
15 Isaacson B, et al.,(53) 2003 Yes  Yes    Yes     1, 3, 7 
16 Wedekind C,et al.,(75) 2003         Yes   9 
17 Grayeli A.B, et al.,(63) 2005       Yes Yes    7, 8 
17 Neff B.A., et al.,(64) 2005       Yes     7 
19 Samii Majid, et al.,(54) 2006 Yes           1 
20 Julian Prell , et al.,(65) 2007          Yes  10 
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The correlation between the sizes of the tumor with the facial function outcome 
after surgery of acoustic tumors has been reported in various studies. Table 4 
compares the outcome of facial nerve function in different tumor size groups. The 
functional preservation rate was 80‐100 % in tumor size less than 2 cm. But there 
was a wide range of 20‐85 % functional preservation rate in tumor size more than 4 
cm.  
                                                                 Table (4) 
Tumor size and facial nerve outcome 
 
S.
N
O 
Author/Year Year 
Number 
of 
Patients 
Facial 
Nerve 
Monitoring
Size of 
Tumor 
( cm ) 
Facial  
Function    
Preservation  
( % ) 
1 Michael V.D, et al.,(66) 1978 79 No < 2 100 
     2 to 4 93 
     > 4 84 
2 Ephraim I.Z, et al.,(67) 1979 120 No < 2 100 
     2 to 4 78.9 
     > 4 35.6 
3 King T.T & Morrison A.W (31) 1980 150 No < 1 100 
     1 to 2.5 80 
     > 2.5 20 
4 Richard H.L, et al.,(32) 1982 33 No < 1 83 
     1 to 2.5 NA 
     > 2.5 70 
5 Ryuzo S, et al.,(39) 1988 89 Yes < 2 89 
     2 to 4 70 
     > 4 77 
6 Tos M & Thomsen J, et al.,(68) 1988 300 No < 2.5 97 
     2.5 to 4 87 
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     > 4 66 
7 Hardy D.G, et al.,(36) 1989 100 No < 2.5 83 
     2.6 to 3.4 85 
     3.5 to 4.4 71 
     > 4.5 61 
8 Ojemann R.G, et al.,(69) 1993 410 Yes < 1 98 
     1 to 1.9 96 
     2 to 2.9 75 
     3 to 4 56 
     > 4 56 
9 Barbara A.E, et al., 1994.(47) 1994 70 Yes < 1.5 96 
     1.6 to 2.5 100 
     > 2.5 85 
10 Grey P.L, et al.,(70) 1996 276 Yes < 1.5 74 
     1.5 to 2.5 62 
     > 2.5 37 
11 Goldbrunner R.H, et al.,(57) 2000 137 Yes < 1 100 
     1 to 1.5 88 
     1.6 to 2.0 90 
     2.1 to 2.5 86 
     > 2.5 45  
12 John T.M, et al.,(71) 2000 100 Yes < 1 100 
     1 to 2.5 98.6 
     2.5 to 4 100 
     > 4 71 
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                                   MATERIAL AND METHODS     
Study design  
           Retrospective analysis of a prospective database. 
Study population   
           100 consecutive cases operated for vestibular schwannoma in Neurosurgery Unit 
1 from September 2003 by a single neurosurgeon were included.  
Inclusion criteria 
1.  Follow up period greater than 3 months. 
2.   Preoperative magnetic resonance imaging of the brain available.  
 
Methods 
            All the patients underwent a retrosigmoid approach and excision of the tumor in 
sitting position with intraoperative electrophysiological monitoring of facial nerve. 
           The patient information were recorded in a proforma (enclosed) which includes 
patients preoperative clinical (facial nerve function) and radiological details along with 
intraoperative (electrophysiological readings) and early postoperative/ follow up clinical 
data.  
ASSESSMENT OF FACIAL NERVE FUNCTION 
                Using the House and Brackmann scale (72), facial nerve function was assessed 
preoperatively,  initially 4‐7 days after surgery and then at follow up.  
HOUSE AND BRACKMANN GRADING OF FACIAL NERVE FUNCTION 
Grade I  ‐  Normal. 
Grade II ‐ Mild dysfunction. 
                 Gross: Slight weakness on close inspection. 
                            May have slight synkinesis 
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                            At rest, normal tone and symmetry. 
             Motion : Forehead moderate to good function 
                            Eye closure complete with minimal effort 
                            Mouth slight asymmetry. 
Grade III – Moderate dysfunction 
                 Gross: Noticeable but not disfiguring difference between the  
                             two sides, noticeable but not severe synkinesis,  hemi‐ 
                             facial spasm, contracture or both  
                            Normal tone and symmetry at rest. 
              Motion: Moderate function of forehead 
                            Eye closure complete with effort 
                            Mouth, slightly weak with maximal effort 
Grade IV – Moderately severe dysfunction 
                  Gross: Obvious weakness/ disfiguring asymmetry at rest. 
                             Normal tone and symmetry at rest. 
               Motion: Forehead none, eye closure incomplete with maximal  
                            effort,  mouth  asymmetric with maximal effort 
Grade V – Severe dysfunction 
                 Gross: Barely perceptible motion, asymmetry at rest. 
              Motion: Forehead none, eye closure incomplete mouth slight  
                             movement.   
Grade VI – Total paralysis.   
 
RADIOLOGICAL DATA 
                                                  
        Only patients who had at least a 3 months follow- up were included in the analysis 
and the following parameters were analysed –  
1. Size of the tumor: largest extrameatal diameter in axial, sagittal, or coronal in 
magnetic resonance imaging scans. 
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2. Brainstem distance:  horizontal distance from anterior lip of internal acoustic 
meatus to the brainstem on the MRI. 
3. Size of the porus : distance between the medial and lateral lip of internal acoustic 
meatus   
4. Facial nerve length: measured intraoperatively from the porus to the root entry zone. 
5. Consistency of the tumor: predominantly solid or cystic  
6. Absolute value of amplitudes at root entry zone and porus. 
7. Absolute value of latencies at root entry zone and porus. 
8. Proximal to distal amplitude and latency ratios. 
 
Facial nerve length measurement   
                Intraoperatively facial nerve length was measured by placing a sterile thread 
along the nerve from the root entry zone to the porus under high magnification. Then 
with the help of a measuring scale the length of the thread was measured.  
Stimulation 
               Stimulation and recording were done using an intraoperative machine 
(Nicholet: Viking IV or Endeavor, Maddison USA). For electrical stimulation of the facial 
nerve, a monopolar platinum tip stimulator was used with a constant current of 0.10 
mA,  frequency of 4.7 Hz and pulse width of  0.5 msec.  
              After complete tumor removal, monopolar stimulation was first done at the 
most proximal part of the facial nerve {exit from the brain stem – root entry zone (REZ)} 
and then at its entry into the porus acousticus (PORUS).  
Recording and Data Acquisition 
             For data acquisition, Intraoperative Monitor (Nicolet Software, USA) with the 
help of an amplifier was used. Compound muscle action potential (CMAP) responses 
were recorded using needle electrodes inserted subdermally into the orbicular muscles 
of the eye, mouth and in the frontalis muscle for three channel recording. During 
dissection stimulation was done using a custom made monopolar platinum electrode.  
                The following stimulation parameters were used during the surgery: 
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Frequency   :   4.7 Hz   
Stimulation duration:  0.5 msec 
Stimulation strength:   0.1 mA. If responses were not obtained at 0.1 mA no attempt to 
increase the current was made.                                                                                                                                        
             The following recording parameters were used during the recording: 
Time base:  50 msec 
Low frequency filter:  10 Hz. 
High frequency filter:  1 KHz. 
Notch filter:  50 Hz 
Reference Electrodes were placed at:  Nasion & Orbicularis oris  
Ground Electrode was placed at :  Masseter 
        CMAP’s were displayed on a monitor screen, and stored into disc for further 
analysis.  
From the stored data the following parameters were extracted : 
CMAP Amplitudes (Fig 2) 
CMAP Latencies (Fig 3) 
 
Fig. 2 CMAP Amplitude of ocular muscle 
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Fig. 3 CMAP Latency of Frontalis muscle 
 
            For statistical analysis of the predictive value of different parameters, a 
multivariate analysis using the logistic regression model was performed. The level of 
significance was set at P < 0.05. For analysis, facial nerve function was categorized as 
good (Grades I/II) and poor (Grade III/IV/ V/VI).  Grades I and II were considered as an 
acceptable function. 
              The accuracy of monitoring parameters in predicting long term function was 
evaluated using 2 × 2 tables. This allowed the calculation of sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) for these 
parameters in predicting good long-term facial nerve outcome.  For the purpose of clarity, 
these terms will be defined. Sensitivity is the probability of parameters to be within the 
defined zone, given that the patient has good outcome. Specificity is the probability that  
parameters will be outside the defined zone, given that the patient has poor outcome. PPV 
is the probability of having good outcome if the parameter is within the defined zone. 
NPV is the probability of having poor outcome if the parameters are outside the defined 
zone. Of these four, probably the PPV and NPV are more valuable in providing 
information helpful in counseling patients regarding their long-term facial nerve function. 
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                                                  RESULTS  
 
 
         Between September 2003 to August 2009, 100 patients with vestibular 
schwannoma were surgically excised via the retromastoid transmeatal approach in the 
sitting position.  The age distribution ranged from 14 to 71 years (mean 42.5 years)  of  
which 47 were men and  53 were women (Fig 4).  There were 55 right-sided and 45 left-
sided tumors.  The average size of the tumor was 4.45 cm (range from 2.4 to 6.5 cm).  
Total tumor excision was done in 89%, subtotal in 9% and partial excision in 1% (as per 
patient’s request) of the patient. There were 7 Neurofibromatosis-2 patients. 
 
 
Fig.4 Sex Distribution 
 
Anatomical and Electrophysiological Facial Nerve Preservation 
           Intraoperatively the facial nerve was anatomically preserved in 86 patients (86%). 
Electrophysiological responses were obtained from the root entry zone in only 77 patients 
(77%).  In 9 patients the facial nerve was only anatomically preserved but no 
electrophysiological responses were obtained.  
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                                                            (Table 5)     
Early facial nerve function in 75 patients according to tumor size        
Size of 
tumor 
(cm) 
House and Brackmann ( Early postoperative period) 
  
Grade I Grade II Grade III Grade IV Grade V Grade VI Total 
< 3 2 (29%) 4 (57%) 1 (14%) 0 0 0 7  
3 - 3.9 5 (22%) 10 (44%) 4 (17%) 4 (17%) 0 0 23  
>/= 4 1 (2%) 18 (41%) 15 (33%) 9 (20%) 2 (4%) 0 45  
Total 8 (10%) 32 (43%) 20 (27%) 13 (17%) 2 (3%) 0 75 
                                                                                                                             
1. Early Postoperative Facial Function    
                                                                                                                                                                  
            Of the 77 patients in whom the facial nerve was preserved both anatomically and 
electrophysiologically, size of the tumor was not available in 2 patients. Of the remaining 
75 patients, good facial function was seen in the early postoperative period in 40 patients 
(53%) and poor in 35 (47%) Table 5. 
            Of the 75 patients, there were only 7 patients (9%) with tumor size less 3 cm and 
among them 6 patients (86%) had good and 1 patient had poor facial nerve function. 
There were 23 patients (31%) with tumor size ranging from 3 – 3.9 cm and among them 
15 patients (66%) had good and, 8 patients (34%) had poor facial nerve function. In the 
remaining 45 patients (60%) tumor size was >/= 4 cm and among them 19 patients (43%) 
had good and 26 patients (57%) had poor facial nerve (Table 5).  
            In the 9 patients in whom the facial nerve was anatomically  
preserved but there were no electrophysiological responses, 1 patient (11 %) had good 
function and 8 patients (89 %) had poor function. 
 
 
 33
2. Long Term Facial Nerve Outcome    
  
           Of the 77 patients in whom the facial nerve was preserved anatomically and 
electro physiologically, 59 patients had long term follow up ranging from 3 months to 6 
years. These 59 patients were analyzed separately. We noted 44 patients (75%) with good 
function and 15 patients (25 %) with a poor facial function. So the long term facial nerve 
functional preservation rate was 75 % (Table 6).  
         In the 9 patients in whom the facial nerve was anatomically  
preserved but there were no electrophysiological responses, 4 (44 %) had good and 4 
patients ( 44 %) had poor long term facial function outcome and 1 patient had no follow 
up.            
                                                               (Table 6)                                                                                                 
Long term facial nerve functions in 59 patients according to tumor size 
Size of 
tumor 
(cm) 
House and Brackmann ( Long term follow up) 
 
Total 
Grade I Grade II Grade III Grade IV Grade V Grade VI 
< 3 5 (83%) 1 (17%) 0 0 0 0 6 (10%) 
3 - 3.9 9 (50%) 5 (28%) 1 (5%) 3 (17%) 0 0 18 (30%) 
>/= 4 9 (26%) 15 (43%) 5 (14%) 6 (17%) 0 0 35 (60%) 
Total 23 (40%) 21 (35%) 6 (10%) 9 (15%) 0 0 59 
        
                                                                                                                                                     
Significance of Immediate Facial Function 
 
            Immediate postoperative facial nerve function was significant in predicting final 
facial nerve outcomes in this study. If the immediate facial nerve function was Grade I to 
II, this had 68.18 % sensitivity, a 100 % specificity, a 100 % positive predictive value 
(PPV), and an 51.7 % negative predictive value in predicting long term facial function 
 34
(Table 7). In other words, a patient with poor facial function in the immediate 
postoperative period, had only a 49.3 % chance of good long term facial function. 
 
                                                   (Table 7) 
Final facial nerve outcome as it relates to immediate postoperative facial nerve 
function in 59 patients. 
House and 
Brackmann  
Final Facial Nerve 
Function             
(Grade I – II) 
Final Facial Nerve 
Function              
(Grade  III – VI) 
Total 
Initial Facial Nerve 
Function             
(Grade  I – II) 
30 0 30 
Initial Facial Nerve 
Function            
(Grade III – VI) 
14 15 29 
Total 44 15 59 
 
Significance of electrophysiological response to the long term facial 
function outcome :         
         As mentioned above, the facial nerve was anatomically preserved in 86 patients 
(86%) but the electrophysiological responses were obtained from the root entry zone in 
only 77 patients (77%). In 9 patients the facial nerve was only anatomically preserved but 
no electrophysiological responses were obtained. We had a total follow up of 67 patients 
(59 among electrophysiological response group and 8 among the later).  
            Analysis of these two groups showed that the presence of electrophysiological 
response in the root entry zone had 91.66 % sensitivity, 21.05 % specificity, 74.57 % 
positive predictive value, and 50 % negative predictive value in predicting long term 
facial function (Table 8). In other words, if a patient has electrophysiological response, 
there is 74.57 % chance that he or she will have a good long term facial function. In 
contrast, a patient with no electrophysiological response has a 50 % chance of having a 
good long term facial function if the seventh nerve was anatomically preserved. 
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                                          (Table 8) 
Electrophysiologica
l response 
House and Brackmann  
(Long term outcome)  Total 
Good  Poor 
Yes  44  15  59 
No  4  4  8 
Total  48  19  67 
  
Compound Muscle Action Potential (CMAP) Amplitude vs Long term 
Facial Function Outcome 
                
                 In the 51 patients in whom complete intraoperative stimulation parameters 
were available; the mean of  CMAP amplitude after proximal stimulation (Root entry 
zone) was 136.28 mV for patients with good postoperative facial nerve function. These 
values decreased with increasing facial nerve damage, 119.96 mV in poor postoperative 
facial nerve function outcome patients,  exhibiting a direct inverse correlation with facial 
nerve function assessed 1 week and more than three months after surgery (Table 9). But 
statistically, there was no correlation with p value of 0.33 (Logistic regression analysis). 
                                                  (Table 9) 
House & 
Brackmann 
Mean CMAP 
Ampl (micro 
volts) 
No. of patients  P value 
I / II 136.28 38 
0.33 
III/IV/V/VI 119.96  13 
 
               Proximal to distal amplitude ratio was analysed and we found  no statistically 
significant correlation with the facial nerve outcome ( p = 0.651 , Logistic regression 
analysis) Table 10. 
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.   
                                                    (Table 10) 
Proximal (REZ) to distal (Porus) amplitude ratio vs long term facial nerve function 
outcome in 51 patients : 
 
 
Sl. 
No. 
Case 
No. Amp REZ Amp Porus 
Proximal to Distal 
Amp Ratio 
(REZ/Porus) 
7th HB 
grade 
Postop 1 
week 
7th HB 
grade 
Postop long 
term f/u 
p value 
1 1 56.4 53.8 1.05 4 4 
0.651 
2 2 81.1 36.2 2.24 2 2 
3 7 28.7 28.3 1.01 3 2 
4 10 77.1 92 0.84 3 2 
5 12 98.6 101.1 0.98 3 3 
6 15 154 198 0.78 2 1 
7 16 36.2 50.3 0.72 2 1 
8 18 81.3 21.3 3.82 2 1 
9 19 28.3 31.2 0.91 2 1 
10 24 36.3 112 0.66 4 3 
11 25 155 162 0.96 3 1 
12 26 464 498 0.93 1 1 
13 27 70.4 119 0.59 3 1 
14 29 186 196 0.95 2 1 
15 31 201 207 0.97 4 3 
16 34 85.6 278 0.31 2 1 
17 36 242 211 1.15 1 1 
18 38 253 162 1.56 2 1 
19 39 79.2 98.8 0.8 2 1 
20 42 157 213 0.74 2 2 
21 43 137 88.2 1.55 3 2 
22 44 17.5 15.8 1.11 2 1 
23 45 10.6 70.8 0.15 5 2 
24 48 86.7 210 0.41 2 2 
25 52 42.1 45.6 0.92 4 4 
26 54 95.9 122 0.79 4 4 
27 55 138 165 0.84 2 1 
28 57 227 241 0.94 2 2 
29 59 61.8 92.7 0.67 3 3 
30 60 50.2 48.2 1.04 4 4 
31 61 41.3 95.3 0.43 2 1 
32 65 110 363 0.3 2 1 
33 68 225 185 1.222 3 2 
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34 74 83.6 102.1 0.82 4 4 
35 76 26.7 36.5 0.73 3 2 
36 77 67.5 91.7 0.74 3 2 
37 78 83.4 102.5 0.81 4 4 
38 80 208 195 1.07 2 1 
39 81 78.4 81.7 0.96 4 2 
40 83 80.6 84.7 0.95 2 1 
41 85 72.7 98.7 0.74 2 2 
42 86 28.5 29.1 0.98 2 1 
43 87 59.7 72.5 0.82 3 1 
44 88 81.6 88.7 0.92 3 2 
45 89 89.6 98.6 0.91 2 2 
46 90 72.4 92.7 0.78 2 2 
7 91 71.2 69.8 1.02 2 2 
48 93 57 78.8 0.72 5 4 
49 95 370 800 0.46 3 3 
50 97 52.5 64.4 0.82 3 2 
51 100 52.9 40.3 1.31 3 4 
 
Compound Muscle Action Potential (CMAP) Latencies vs Facial 
Outcome               
             The mean value of CMAP latency after proximal stimulation (Root entry zone) 
was 9.89 msec for patients with good postoperative facial nerve function and 9.90 msec 
in patients with poor  postoperative facial nerve function (Table 11). Statistical analysis 
showed no significant correlation with the facial nerve outcome,  p value of  0.77 
(Logistic regression analysis) . 
                                                       (Table 11)   
House & Brackmann Mean Latency (msec) No. of patients p value 
I / II 9.89  38 
0.77 
III/IV/V/VI 9.90  13 
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             Proximal to distal latency ratio was analysed and we found no significant 
correlation with the facial nerve outcome ( p = 0.715 , Logistic regression analysis) Table 
12.   
 
                                                                (Table 12)   
Proximal (REZ) to distal (Porus) latency ratio vs long term facial nerve function 
outcome in 51 patients : 
S.No Case No. 
Latency  
REZ 
Latency 
Porus 
 Proximal to 
distal latency 
ratio 
(REZ/Porus) 
7th HB 
grade 
Postop 1 
week 
7th HB 
grade 
Postop 
long term 
f/u 
p value 
1 1 7.2 6.5 1.11 4 4 
0.715  
2 2 20.4 16.2 1.26 2 2 
3 7 6.7 6.8 0.99 3 2 
4 10 14.1 9.8 1.44 3 2 
5 12 8.1 6.8 1.19 3 3 
6 15 9.2 6.4 1.44 2 1 
7 16 13.7 9.7 1.41 2 1 
8 18 7 6 1.67 2 1 
9 19 7.3 6.5 1.12 2 1 
10 24 13.5 11 1.23 4 3 
11 25 6.5 5.5 1.18 3 1 
12 26 11.2 9.3 1.2 1 1 
13 27 8.6 6.7 1.28 3 1 
14 29 6.8 5.6 1.21 2 1 
15 31 9.1 5.6 1.63 4 3 
16 34 8.7 6.8 1.28 2 1 
17 36 9.3 7.3 1.27 1 1 
18 38 9 6.7 1.34 2 1 
19 39 7.6 6.5 1.17 2 1 
20 42 6.2 5.2 1.19 2 2 
21 43 11 7.5 1.47 3 2 
22 44 10.8 8.9 1.21 2 1 
23 45 9.3 6.9 1.35 5 2 
24 48 9.2 5.7 1.61 2 2 
25 52 8.9 7.1 1.25 4 4 
26 54 8.7 6.3 1.38 4 4 
27 55 7.7 6.4 1.2 2 1 
28 57 9.7 7.5 1.29 2 2 
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29 59 10.8 9.5 1.14 3 3 
30 60 8.2 6.2 1.32 4 4 
31 61 10.1 6.4 1.58 2 1 
32 65 9.4 6.1 1.54 2 1 
33 68 7.2 6.2 1.16 3 2 
34 74 8.9 5.1 1.75 4 4 
35 76 5.9 5.2 1.13 3 2 
36 77 9.1 5.7 1.6 3 2 
37 78 9.8 9.1 1.08 4 4 
38 80 6.5 5.7 1.14 2 1 
39 81 8.9 8.2 1.09 4 2 
40 83 7 6.2 1.13 2 1 
1 85 10.5 9 1.17 2 2 
42 86 8.7 7.9 1.1 2 1 
43 87 8.38 7.9 1.06 3 1 
44 88 9.2 8.1 1.14 3 2 
45 89 7.9 6.4 1.23 2 2 
46 90 8.1 7.2 1.13 2 2 
47 91 7.2 6.5 1.11 2 2 
48 93 12.6 7.5 1.68 5 4 
49 95 8.3 6.7 1.24 3 3 
50 97 8.5 8 1.06 3 2 
51 100 9.7 9.1 1.07 3 4 
 
1. TUMOR SIZE vs FACIAL NERVE FUNCTION OUTCOME 
 
               There were 59 patients in whom the tumor size and the long term facial nerve 
function outcomes were available. There were only 6 patients in whom the tumor size 
was less than 3 cm and all of them had good facial nerve function outcome. There were 
18 patients whose tumor size were between 3 and < 4 cm and out of them 14 patients had 
good and 4 patients had poor facial nerve function outcome. There were 35 patients in 
whom the tumor size was equal to more than 4 cm (termed as “giant vestibular 
schwannomas”) and out of them 24 patients had good and 11 patients had poor facial 
nerve function outcome (Table 13and Fig.5). Statistically there was no significant 
correlation between the size of the tumor and the long term facial nerve function outcome 
(p = 0.822).                                               
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                                                             (Table 13) 
Tumor size vs Postoperative long term facial nerve function outcome in 59 acoustic 
neurinoma patients.   
House and 
Brackmann Grade 
Tumor Size 
Small              
( < 3 cm ) 
Medium            
( 3 - 3.9 cm ) 
Giant               
( > / = 4 cm ) 
I / II    6 (100%)    14 (78%)  24 (69%) 
III / IV /V / VI          0     4 (22%) 11 (31%) 
Total          6          18        35 
 
 
 
Fig.5  Tumor size vs Postoperative long term facial nerve function outcome in 59 
acoustic neurinoma patients: ).   
 
2. BRAINSTEM DISTANCE vs FACIAL NERVE FUNCTION OUTCOME 
 
            There were 59 patients in whom the brainstem distance and long term facial 
nerve function outcomes were available. There were 13 patients  in whom the brainstem 
distance was less than or equal to 2 cm and out of them 10 patients had good and 3 
patients had poor facial nerve function outcome in the long term postoperative period.  
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There were 46 patients with the brainstem distance more than 2 cm and out of them 34 
patients had good and 12 patients had poor facial nerve function outcome in the long term 
postoperative period (Table 14 & Fig. 6).  Statistically there was no significant 
correlation between the brainstem distance and the long term facial nerve function 
outcome (p = 0.131, Logistic regression analysis).  
 
                                                            (Table 14)        
Brainstem distance vs postoperative facial nerve function outcome in 59 acoustic 
neuroma patients         
House and Brackmann 
Grade 
Brainstem Distance 
< /= 2 cm > 2 cm 
I / II 10  34 
III / IV / V / VI  3 12 
Total 13  46  
 
 
Fig. 6 Brainstem distance vs Postoperative facial nerve function outcome in 59 
acoustic neuroma patients. 
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3. PORUS SIZE vs FACIAL NERVE FUNCTION OUTCOME  
 
               There were 59 patients in whom the porus size and long term facial nerve 
function outcomes were available.  There were 23 patients in whom the porus size was 
less than 1 cm and out of them 18 patients had good and 5 patients poor facial nerve 
function outcome in the long term postoperative period.  There were 36 patients with the 
porus size was more than or equal to 1 cm and out of them 26 patients had good and 10 
patients had poor facial nerve function outcome in the long term postoperative period 
(Table 15 / Fig. 7).  Statistically there was no significant correlation between the porus 
size and the long term facial nerve function outcome (p = 0.220, Logistic regression 
analysis). 
                                              (Table 15)                   
Porus size vs Postoperative facial nerve function outcome in 59 acoustic  
neurinoma patients.    
House and Brackmann 
Grade 
Porus Size 
< 1 cm > / = 1 cm 
I / II 18  26 
III / IV /V / VI  5 10 
Total 23 (39%) 36 (61%) 
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Fig. 7 Porus size vs Postoperative facial nerve function outcome in 59 acoustic 
neurinoma patients                          
 
4. FACIAL NERVE LENGTH vs FUNCTIONAL OUTCOME  
 
          Out of the total 58 patients with long term follow up, 53 patients had facial nerve 
length documented. So, we analyzed these 53 patients.  There were 3 patients (5%) in 
whom the facial nerve length was less than or equal to 2 cm and out of them 2 patients 
had good and 1 patient  had poor facial nerve function outcome  in the long term 
postoperative period.  There were 50 patients (95%) with the facial nerve length  more 
than 2 cm and out of them 38 patients had good and 12 patients had poor facial nerve 
function in the long term postoperative period (Table 16/ Fig. 8).  Statistically there was 
no significant correlation between the facial nerve length and the long  term facial nerve 
function outcome ( p= 0.641, Logistic regression analysis). 
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                                                                (Table 16)  
Facial nerve length vs Postoperative facial nerve function outcome in 53 acoustic 
neurinoma patients.  
 
 
 
 
 
 
 
 
 
 
Fig. 8 Facial nerve length vs Postoperative facial nerve function outcome in 53 
acoustic neurinoma patients. 
 
 
 
 
 
House and Brackmann 
Grade 
Facial Nerve Length 
< / =  2 cm > 2 cm 
I / II 2 38 
III / IV / V /VI   1 12 
Total 3 (5%) 50 (95%) 
 45
5. SOLID / CYSTIC TUMORS vs FACIAL NERVE FUNCTION OUTCOME 
  
             Out of the total 59 patients with long term follow up, tumor was predominantly 
solid in 54 patients and out of them 40 patients had good and 14 patients had poor facial 
nerve function outcome in the long term postoperative period.  There were 5 patients with 
tumor predominantly cystic and out of them 4 patients had good and only 1 patient had 
poor facial nerve function outcome in the long term postoperative period (Table 17 / Fig 
9).  Statistically there was no significant correlation between the solid and cystic nature 
of tumor with the long term facial nerve function outcome ( p =  0.518, Logistic 
regression analysis ). 
Tumor consistency vs Postoperative facial nerve function outcome in  59 acoustic 
neurinoma patients.  (Table 15).    
House and Brackmann 
Grade 
SOLID CYSTIC 
I / II 40 4 
III / IV / V / VI 14 1 
Total 54 (92%) 5 (8%) 
 
        
Fig. 9Tumor consistency vs Postoperative facial nerve function  outcome in  59 
acoustic neurinoma patients. 
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  Grade II 
  Grade I 
Fig.10 Patient with left-sided acoustic tumor 1wk after total excision and 1 year later. 
  Grade II 
  Grade I 
Fig.11 Patient with left-sided acoustic tumor 1wk after total excision and a year later. 
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  Grade II 
 Grade II 
Fig.12 Patient with right-sided acoustic tumor 1wk after total excision and 7 months later. 
   Grade III 
  Grade III 
Fig.13 Patient with right-sided acoustic tumor 1wk after total excision and 3 months later. 
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 Grade III 
 Grade II 
Fig.14 Patient with left-sided acoustic tumor 1wk after total excision and 4 months later. 
 
  Grade IV 
  Grade III 
Fig.15 Patient with left-sided acoustic tumor 2wks after total excision and 1 year later. 
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 Grade V 
 Grade V 
Fig.16 Patients with right-sided acoustic tumors 8 months after total excision. 
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                                                   DISCUSSION 
 
 
             Intraoperative monitoring has greatly enhanced the surgeons ability to preserve 
both anatomic and functional integrity of cranial nerves.  The morbidity of 
cerebellopontine angle surgery has significantly decreased (40, 41).  With the 
introduction of intraoperative monitoring the functional preservation of the facial nerve 
has improved from 77% to 95% (48, 36). The immediate feedback offered by the use of 
intraoperative facial nerve monitoring greatly enhances the surgeon’s ability to modify 
the dissection for maximal preservation of function.     
               An association between initial and final facial nerve function after the excision 
of acoustic neuromas has been established in the literature. In a study by Arriaga, et al. 
1993 (44) in 515 patients showed  99% of patients with good initial facial nerve function 
had good final facial nerve function postoperatively. 73% of patients with fair initial 
function had good final facial nerve function, and in 28% final facial nerve function 
remained fair. 25% of patients with poor initial facial nerve function postoperatively had 
good, 52% had fair, and 23% had poor final facial nerve function. 
             Our results are similar (Table 16), 100% of the patients with good initial facial 
nerve function had good final facial nerve function postoperatively. 48% of patients with 
poor initial facial function postoperatively had good outcome and remaining 52% had 
poor final facial nerve function in the long term. So, based on the initial facial nerve 
function postoperatively, the surgeon can estimate final facial nerve function but cannot 
predict which patient will have facial nerve recovery to what degree.        
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                                                            (Table 16)  
 Final facial nerve outcome as it relates to initial postoperative facial nerve 
 function in 59 patients. 
Initial Facial NerveFunction     
(1week) 
Final Facial Nerve Function            
(> 3 months)               
Good (I-II) Poor (III-VI) Good (I-II) Poor (III-VI) 
30 0   30 (100%)              0 
0 29 14 (48%)  15 (52%) 
30 29             44            15 
              
Facial Nerve Preservation 
 
         The preservation of facial nerve has always been considered to be a primary 
concern in acoustic neuroma surgery, particularly in patients with a large tumor, in whom 
the nerve is usually adherent to the surface of the tumor. Table 4 summarizes the facial 
nerve functional preservation rate of tumors of various size ranges from a number of 
studies. Direct comparison between the studies should be made only with extreme 
caution, because the number of cases, experience of surgeons over the course of the 
reported series, methods used to measure tumor size, use of  intraoperative monitoring, 
and criteria for choosing the approach are not necessarily equivalent across studies. The 
anatomical preservation of the facial nerve is not equivalent to functional preservation. 
For acoustic neuromas, the larger the tumor size, the more difficult it is to maintain the 
integrity of the facial nerve (73). Criteria for preservation of facial nerve function may 
differ from one study to another. Where possible we have presented the percentage of 
patients achieving a House and Brackmann Grade II or better as an acceptable functional 
outcome. Frequently, results were not reported for size categories. In addition, procedures 
performed before and after the advent of facial nerve monitoring were often combined. 
Thus, the comparisons between the listed studies must be made only with caution. The 
functional preservation rate was 80 -100% in tumor size less than 2 cm and 56 – 100% in 
tumor size between 2 to 4 cm. But there was a wide range 20 – 85 % in the rate of 
functional preservation in tumor size more than 4 cm. In our study we found 100% 
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functional preservation rate in tumor size less than 3 cm and 78% functional preservation 
rate in the tumor size range 3 to  < 4cm and 69%  in those with giant vestibular 
schwannomas (>/ = 4cm) (Table 13). 
 
Predictive Value of Electrophysiological Studies 
              There have been several reports of utilizing intraoperative facial nerve 
monitoring parameters to predict facial nerve outcomes (Table 3). In our study we look 
into the absolute values of compound muscle action potential amplitudes and latencies at 
root entry zone, and proximal to distal amplitude and latency ratios. Review of literature 
of utility of intraoperative facial nerve monitoring parameters to predict facial nerve 
outcomes revealed that proximal to distal amplitude ratio was the most powerful 
parameter for intraoperative assessment of postoperative facial nerve function (40, 48, 56, 
57, 53). However, in our study we could not establish any correlation between the 
compound muscle action potential amplitudes and latencies at root entry zone and 
proximal to distal amplitude and latency ratios to the initial and long term facial nerve 
function outcome. A few possibilities of not getting a correlation might be 1) Wrong 
identification of root entry zone, or 2) Interobserver variability in assessing House and 
Brackmann grading of facial function. But various studies has shown high inter-observer 
reliability (93%) of House and Brackmann grading system for facial function(76). 
                 In our study we found that there was a tendency to get a higher CMAP 
amplitude (136.28 mV) in patients with good facial function outcome as compared to the 
poor outcome ones (119.96 mV). But there was no statistical correlation. It might be due 
to very few number of patients with poor facial function outcome (only 13 out of 51 
patients) (Table 9).  
              Parameters other than intraoperative monitoring have also been analyzed in our 
study. Brainstem distance (horizontal distance from anterior lip of internal acoustic 
meatus to the brainstem on the MRI), consistency of the tumor (predominantly solid or 
cystic), size of the porus (distance between the medial and lateral lip of internal acoustic 
meatus) and facial nerve length (measured intraoperatively from the porus to the root 
entry zone) in relation to long term facial nerve function outcome. None of these 
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parameters has been analysed before our study. Statistical analysis of these parameters 
failed to correlate to the initial and long term facial nerve function outcome.   
               There were 9 patients in whom the facial nerve was anatomically preserved but 
there were no electrophysiological responses.  Functionally in the immediate and early 
postoperative period 1 patient (11 %) had good function and 8 patients (89 %) had poor 
function. In the long term follow up, out of these 9 patients, 4 (44 %) had good facial 
function and 4 patients (44 %) had poor facial function and 1 patient had no follow up. 
Perhaps this can be explained by neurapraxia or axonotomesis where neural conduction 
improves spontaneously or by regeneration after the injury. This shows that if the facial 
nerve is anatomically preserved but electro physiologically not preserved, there is still a 
very good chance (50%) of functional preservation of facial nerve in the long term follow 
up (Table 8). 
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                                                 CONCLUSION 
 
                   
               While a positive response to facial nerve stimulation at the end of a vestibular 
schwannoma surgery is a good predictor of long term postoperative facial nerve function, 
the absence of responses did not mean that the function would be poor. Our functional 
preservation rate was 75%.                                      
              Proximal-to-distal amplitude and latency ratios did not correlate with the final 
facial nerve function. 
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                                                      PROFORMA - (ANNEXURE I) 
 
 
 
     
     Date of Surgery:                  Size of Tumor (Largest dimension):  
     
    Duration of Symptoms: 
 
     Brain Stem                                                        
     Distance: 
      (Horizontal Length to the 
           Brain Stem)                   
7th H & B Grade 
                                                                                    
      Extent of excision: 
 
 
 
       Tarsorrhaphy:                                                               Followup Duration 
 
 
      
  
 
                                                                                                                   
                                                              
 
       Facial Nerve length ( cm)  
 
 
         
 
 
 
 
 
 
Facial 
nerve 
stimulation 
at end of 
surgery 
Minimum 
Current 
(mA) 
Amplitude 
(microV) 
 
 
Latency 
(msec) 
REZ    
Porus    
Serial Number:   Hospital Number : 
Name:                             Age:                     Gender:  
Address: 
Unit:        1       
 
           Predominantly cystic 
                Yes / No Porus Size= 
Subtotal = 1 
Total = 2
Partial    = 3   Preop                   Postop 1 Week      Postop followup 
Y N
7th saved      Yes / No Responses at REZ    Yes / No 
Responses at porus    Yes / No      
Phone Number/ Email:                                                   
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 HOUSE AND BRACKMANN GRADING OF FACIAL NERVE FUNCTION 
Grade I ‐ Normal. 
Grade II ‐ Mild dysfunction. 
                 Gross: Slight weakness on close inspection. 
                            May have slight synkinesis 
                            At rest, normal tone and symmetry. 
             Motion : Forehead moderate to good function 
                            Eye closure complete with minimal effort 
                            Mouth slight asymmetry. 
Grade III – Moderate dysfunction 
                 Gross: Noticeable but not disfiguring difference between the  
                             two sides, noticeable but not severe synkinesis,  hemi‐ 
                             facial spasm, contracture or both  
                            Normal tone and symmetry at rest. 
              Motion: Moderate function of forehead 
                            Eye closure complete with effort 
                            Mouth, slightly weak with maximal effort 
Grade IV – Moderately severe dysfunction 
                  Gross: Obvious weakness/ disfiguring asymmetry at rest. 
                             Normal tone and symmetry at rest. 
               Motion: Forehead none, eye closure incomplete with maximal  
                            effort,  mouth  asymmetric with maximal effort 
Grade V – Severe dysfunction 
                 Gross: Barely perceptible motion, asymmetry at rest. 
              Motion: Forehead none, eye closure incomplete mouth slight  
                             movement.   
Grade VI – Total paralysis. 
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                                                    MASTER TABLE (ANNEXURE II) 
 
Ca
se 
No
. 
Age/  
Gen
der 
Larg
est 
dia
met
er 
(cm) 
Brai
nste
mdi
stan
ce 
(cm) 
Pre
dom
inan
tly 
cysti
c 
Por
us 
size 
/ cm 
Ext
e 
nt 
of 
exci
sion 
7th 
HB 
grad
e 
Preo
p 
7th 
HB 
grad
e 
Post
op 1 
wee
k 
7th 
HB 
grad
e 
Lon
g 
term 
follo
w 
up 
7th 
sav
ed 
Res
pon
se 
at 
REZ 
Res
pon
se 
at 
poru
s 
Faci
al 
nerv
e 
leng
th / 
cm 
Curr
ent 
stre
ngth 
REZ 
/ 
mA 
Am
p1 
REZ 
/ 
micr
o V 
Am
p 2 
REZ 
/ 
micr
o V 
Am
p 3 
REZ 
/mic
ro V 
Lat 
1 
REZ 
/ m 
sec 
Lat 
2 
REZ 
/ m 
sec 
Lat 
3 
REZ 
/ m 
sec 
Curr
ent 
stre
ngth 
Por
us /   
mA 
Am
p 1 
Por
us / 
micr
o V 
Am
p 2 
Por
us  / 
micr
o V 
Amp 
3 
Poru
s / 
micr
o V 
Lat 1 
Poru
s / m   
sec 
Lat 2 
Poru
s / m 
sec 
Lat 3 
Poru
s / m 
sec 
1 26M 3.2 2.1 No 0.4 T I IV IV Yes Yes Yes 2.7 0.1 56.4 38.6 81.7 8.4 7.8 7.2 0.1 53.8 49.6 123.5 8.1 7.2 6.5 
2 40F 4.1 2.29 No 1.5 S II II II Yes Yes Yes 2.6 0.1 81.1 16.2 75.4 20.4 15.2 14.4 0.1 36.2 20.9 74.2 16.2 16.8 13.7 
3 33F 4.2 2 No 0.5 T II II No FU Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
4 50F 
No 
film 
in 
PA
CS 
# No # S II IV III Yes Yes Yes ND 0.1 ND ND ND ND ND 0.1 0.1 ND ND ND ND ND ND 
5 48M 4.2 3.4 No 1.2 T II IV NO F/U Yes Yes Yes 3.5 0.1 37.7 41.8 
170.
2 14.2 11.2 11.2 0.1 206 233 240 9.3 7.9 10.1 
6 41M 4 2.9 No 1 T II II NO F/U Yes Yes Yes 3 0.1 228 57.3 53.2 7.3 6.5 6.6 0.1 238 60.1 139 6.1 5.5 5.2 
7 41M 3.9 3.3 No 1 T II III II Yes Yes Yes 3 0.1 28.7 13.3 10.5 8.4 6.7 6.7 0.1 28.3 14.4 27.6 9.5 6.8 7.4 
8 44M 4.6 3.1 No 0.8 T II II NO F/U Yes Yes Yes 1.5 0.1 220 68.4 24.2 10.7 8.3 7 0.1 164 62.2 33.5 10.3 7.8 6.8 
9 24M 2.8 1.2 No 1 T II IV IV 
7th 
not 
see
n 
No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
10 45F 4.2 1.6 No 0.8 T II III II Yes Yes Yes 2.8 0.1 80.2 77.1 28.5 14.9 15.1 14.1 0.1 234 92 94.8 10.5 12.5 9.8 
11 41M 4.4 3 No 1.2 T II II NO F/U Yes Yes Yes 1.8 0.1 48.8 28.1 15.1 7.9 11 14.3 0.1 50.7 39.2 56.7 7.1 10.8 14 
12 19M 6 2.6 No 0.6 T I III III Yes Yes Yes 3.5 0.1 47.9 10.5 98.6 10.4 7 8.1 0.1 61.5 45.1 101.1 10.1 6.5 6.8 
13 45F 4 2.8 No 0.4 T II V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
14 14M 3 1.5 No 0.4 T I III II Yes No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
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15 42F 3.7 2.9 Yes 1 T I II I Yes Yes Yes 3.5 0.1 62.5 22.8 154 7.5 9.2 7.7 0.1 137 41.7 198 6.8 6.4 6.1 
16 42M 4.2 2.5 No 0.8 T II II I Yes Yes Yes 3 0.1 9.07 36.2 33.2 13.7 11.5 17.2 0.1 39 50.3 85 9.7 10.6 14 
17 47F 3.2 2.2 No 0.9 T I III NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
18 36M 2.5 2.4 No 1.2 T I II I Yes Yes Yes 3.4 0.1 94.8 81.3 71.8 11 10.8 7 0.1 60.5 21.3 85.3 9.2 6.7 6 
19 51F 4.3 2.6 Yes 1 T II II I Yes Yes Yes 2.4 0.1 28.3 31.7 95.2 8.6 8.2 7.3 0.1 31.2 48.6 116.2 8.2 7.9 6.5 
20 33F 3.1 2.4 No 1.3 S I III III Yes Yes No ND 0.1 68.5 72.6 206.8 7.6 8.2 6.9 0.1 0 0 0 0 0 0 
21 37M 4.4 3.8 No 1.1 T I V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
22 28F 4.5 2.8 No 1 P III III NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
23 49F 3 1.2 No 0.5 T I I I Yes Yes Yes 2.2 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
24 32M 5.3 2.7 No 1 T I IV III Yes Yes Yes 3 0.1 27.2 36.3 80.3 14.6 13.5 11 0.1 112 55.4 198 12.8 11 10.4 
25 27M 4 3.2 No 1.1 T II III I Yes Yes Yes 2.6 0.1 155 110 234 7.3 6.6 6.5 0.1 162 253 298 6.8 5.9 5.5 
26 36F 3.2 1.6 No 0.6 T I I I Yes Yes Yes 2.6 0.1 25.1 25.5 464 6.7 11.2 6.4 0.1 56.2 69.1 498 5.9 9.3 5.6 
27 52M 2.5 1.25 No 0.4 T I III I Yes Yes Yes 2.7 0.1 120 123 70.4 8.6 10.3 11.4 0.1 234 244 119 6.7 9 10.3 
28 53M 5.6 4 No 1.8 S II II II Yes Yes Yes 2.5 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
29 55F 3.2 1.8 No 0.7 T II II I Yes Yes Yes 2.5 0.1 174 22.1 186 7.7 11.2 6.8 0.1 245 28.5 196 7.1 10.5 5.6 
30 40M 4 2.5 Yes 0.6 T II III I Yes No No 2.2 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
31 25F 4.6 3.4 No 1.1 T II IV III Yes Yes Yes 3.2 0.1 87.3 28.8 201 7 9.1 6.1 0.1 264 135 207 5.4 5.6 5.1 
32 33F 5.3 1.8 No 1 T II IV NO F/U Yes No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
33 22M 5 3 No 1.2 T I V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
34 35M 4.1 3.2 Yes 1 T II II I Yes Yes Yes 3 0.1 85.6 50.8 68.9 8.7 7.9 7.7 0.1 278 212 251 6.8 6.4 6.2 
35 36M 4.8 2.4 No 0.4 T II III NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
36 48F 2.5 1.2 No 0.9 T I I I Yes Yes Yes 1.3 0.1 103 46.3 242 9.3 7.6 6.2 0.1 92.2 75.5 211 7.3 7.2 5.1 
37 55M 5.6 4.4 No 1.6 T II II NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
38 25F 3.8 2.5 No 0.8 T II II I Yes Yes Yes 2.7 0.1 253 65 427 6.5 9 7.3 0.1 162 75.5 486 6.2 6.7 6.5 
39 59M 3.2 2.6 No 0.8 T II II I Yes Yes Yes 2.5 0.1 79.2 58.9 116 9.5 8.2 7.6 0.1 98.8 76.4 254.1 8.6 7.4 6.5 
40 41M 6.5 2.5 No 0.9 T II VI NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
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41 25F 3.6 3.1 No 1.5 T II I NO F/U Yes Yes Yes 2.9 0.1 93.1 39.1 350 9.8 8.5 6.3 0.1 198 54.5 402 8 7.3 6.1 
42 44F 3.1 1.7 No 0.8 T II II II Yes Yes Yes 2.5 0.1 92.5 182 157 5.7 5.6 6.2 0.1 213 314 213 5.1 5.4 5.2 
43 39F 4.4 3.3 No 1.9 T II III II Yes Yes Yes 2.8 0.1 109 137 95.4 11 9.4 8.3 0.1 158 88.2 220 7.5 7.4 6.5 
44 58F 3.4 2.2 No 1.3 T I II I Yes Yes Yes 2.3 0.1 62.5 10.6 17.5 9.1 10.8 9.4 0.1 63.8 14.5 15.8 7.8 8.9 9.2 
45 52M 4 2.3 No 0.5 T II V II Yes Yes Yes 2.6 0.1 0 0 10.6 0 0 9.3 0.1 95.2 61.6 70.8 7.5 7.7 6.9 
46 27F 4 3.4 No 1.6 S II III NO F/U Yes Yes Yes 2.2 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
47 42M 4.7 3.3 No 0.8 T III V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
48 22M 6.3 4 No 1.2 S II II II Yes Yes Yes 3.6 0.1 47.2   86.7 10.4 8.3 9.2 0.1 242 151 210 6.6 5.8 5.7 
49 59M 4.4 1.9 No 0.5 T I I I Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
50 57F 4 3 No 1.2 T II III II Yes Yes Yes 2.5 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
51 29M 
NO 
SC
ALE 
# No # S II IV NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
52 56F 4.4 3.2 No 1 T I IV IV Yes Yes Yes 3 0.1 62.3 42.1 10.2 8.9 8.1 8.6 0.1 93.7 45.6 18.8 7.1 7.5 7.3 
53 45F 2.4 1.9 No 0.7 T II I NO F/U Yes Yes Yes 1.8 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
54 52M 4.6 4 No 1 T I IV IV Yes Yes Yes 2.6 0.1 39.8 39.8 95.9 8.7 7.9 8.6 0.1 88.6 101 122 6.3 7.9 6.7 
55 50M 4.5 2.9 No 1.5 T II II I Yes Yes Yes 2.7 0.1 33.8 23.4 138 7.7 9 7.5 0.1 59.3 29.5 165 6.4 8 6.7 
56 42F 2.5 1.3 No 0.4 T I II I Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
57 32M 3.5 3 No 1.1 T II II II Yes Yes Yes 3 0.1 227 212 169 8.8 9.7 7.3 0.1 241 385 183 6.8 7.5 6.2 
58 40F 4.5 3.4 No 0.6 T II III NO F/U Yes Yes Yes 3.5 0.1 19.1 25.8 10.2 9.6 8.9 7.3 0.1 35.4 33.2 14.6 9.4 8.6 7.1 
59 16M 4.3 3.6 No 1.6 T II III III Yes Yes Yes 3.7 0.1 72.1 61.8 108.5 10.8 10.6 8.2 0.1 
121.
5 92.7 
231.
8 9.5 9.8 8.1 
60 45F 3.8 1.9 No 0.9 T II IV IV Yes Yes Yes 3.2 0.1 49.7 50.2 143 8.1 8.8 8.2 0.1 237 48.2 238 7.2 7 6.2 
61 45F 3.5 3 No 0.6 T II II I Yes Yes Yes 4 0.1 41.3 31.2 27.3 8.4 9.8 10.1 0.1 95.3 81.7 110 6.9 8 6.4 
62 24F 4 3.4 No 1.3 T II IV NO F/U Yes No Yes 2.8 0.1 0 0 11.3 0 0 9.8 0.1 150 157 94.3 13.4 11.9 9.8 
63 64M 4 2.5 No 0.7 T II V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
64 65M 4.3 2.5 No 0.8 T II II II Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
65 49F 4.2 2.4 No 1 T II II I Yes Yes Yes 2.8 0.1 25.8 43.8 110 9.4 7.4 7.6 0.1 183 323 363 6.1 6.6 5.6 
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66 67F 4 1.5 No 1 T III V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
67 23M 6 3.5 No 1 T I IV III YES No No 3.5 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
68 40M 3.6 2.8 No 1.5 T II III II Yes Yes Yes 3.3 0.1 194 225 178 7.2 5.8 6.2 0.1 241 185 215 6.2 8.5 6.5 
69 32F 3.2 1.3 No 1.4 S I I NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
70 71M 3.6 2.4 No 0.6 T I IV NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
71 31M 5 2.3 No 1 T I IV IV Yes No No 3.5 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
72 57F 3.5 1.6 Yes 0.5 T I I NO F/U Yes Yes Yes ND 0.1 ND ND ND ND ND ND 0.1 ND ND ND ND ND ND 
73 45F 3 1.4 Yes 0.7 T III V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
74 22F 4.7 3.1 No 0.8 T II IV IV Yes Yes Yes 2.8 0.1 83.6 92.6 75 8.9 7.9 7.8 0.1 102 228 344 5.1 5.8 5.6 
75 38M 4.8 3.1 No 1.1 T II V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
76 33M 5 2.8 No 1.2 T II III II Yes Yes Yes 3.2 0.1 26.7 28.4 52 6.8 7.3 5.9 0.1 36.5 61.4 102.7 6.1 6.5 5.2 
77 31F 5.4 3.7 No 1.8 T II III II Yes Yes Yes 6.1 0.1 40.6 43.9 68 11 9.1 10 0.1 175 68.2 91.7 6.8 5.7 6.4 
78 54F 3.8 3.2 No 1.4 T II IV IV Yes Yes Yes 4.5 0.1 83.4 56.5 93 9.8 8.4 7.2 0.1 103 92.7 121.6 9.1 8 6.8 
79 38M 4 2.5 No 1 T II V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
80 31F 2.4 2.2 Yes 1.7 S II II I Yes Yes Yes 2.5 0.1 147 185 208 6.5 6.8 6 0.1 217 205 195 5.7 6.1 5.5 
81 65M 4.3 2.9 No 1 T II IV II Yes Yes Yes 2.5 0.1 78.4 86.5 112 8.9 8.6 7.2 0.1 81.7 92.5 182.6 8.2 8.1 6.9 
82 46M 3 2.5 No 0.7 T II VI V Yes No Yes 2.2 0.1 0 0 0 0 0 0 0.1 56.5 47.1 83.2 10.2 9.6 9.1 
83 27F 4.7 2.6 No 1 T II II I Yes Yes Yes 2.3 0.1 76.5 80.6 122 8.4 8.6 7 0.1 146 84.7 201.5 7.8 7.9 6.2 
84 35F 4 2.3 No 0.8 T III V NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
85 41M 3.7 2.4 No 0.9 T II II II Yes Yes Yes 3 0.1 217 72.7 101 10 10.5 9.4 0.1 343 98.7 194.5 9.8 9 8.6 
86 34F 3.2 2.4 No 1 T II II I Yes Yes Yes 2.3 0.1 53.2 28.5 61 9.7 8.8 8.7 0.1 57.5 29.1 72.5 9.1 8.5 7.9 
87 57F 4 2.8 No 0.9 T II III I Yes Yes Yes ND 0.1 59.7 66.4 59 9.8 7.5 8.4 0.1 72.5 88.4 92.7 9.5 7.1 7.9 
88 20F 5.2 3.6 No 1.3 T II III II Yes Yes Yes 2.7 0.1 57.5 81.6 106 8.8 9.2 7.9 0.1 85.6 88.7 127.6 7.9 8.1 7 
89 45M 4.2 2.7 No 1.1 T II II II Yes Yes Yes 3.8 0.1 98.5 89.6 122 8.8 8.2 7.9 0.1 157 98.6 225.7 8 7.4 6.4 
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90 58F 2.8 1.5 No 1 T II II II Yes Yes Yes 1.3 0.1 56.5 72.4 86 8.5 8.8 8.1 0.1 103 92.7 156.8 8.2 8.1 7.2 
91 30F 5.8 2.4 No 0.8 T II II II Yes Yes Yes 2.6 0.1 63.5 71.2 90 8.7 8.9 7.2 0.1 74.6 69.8 128.7 8.2 8.1 6.5 
92 44F 4 2 No 0.8 T II IV IV Yes Yes Yes ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
93 42M 5.1 3.9 No 1.6 T II V IV Yes Yes Yes 4 0.1 25.1 29 57 13 11.5 13 0.1 55 65.5 78.8 7.5 7.8 8.5 
94 49F 4.2 2.5 No 1 T II VI V Yes No No 3 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
95 40F 4.5 3.5 No 0.9 T II III III Yes Yes Yes 3.5 0.1 370 120 388 8.3 7.2 7.5 0.1 800 356 900 6.7 6 7 
96 67F 3.5 2.8 No 1 T II II I Yes No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
97 68F 4 3.3 No 1.1 T II III II Yes Yes Yes 3 0.1 52.5 92.7 218 8.8 8.5 7.2 0.1 64.4 117 327 8.6 8 6.8 
98 47M 4.3 2.3 Yes 0.7 T II III NO F/U No No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
99 44F 2.8 2 No 0.4 T II III II Yes No No ND 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 
10
0 38F 4.5 2 Yes 1 T II III IV Yes Yes Yes 1.1 0.1 58.1 52.9 34 9.2 8.7 9.7 0.1 69.7 40.3 37.2 8.9 8.5 9.1 
 
ND – Not documented, T – Total; S- Subtotal; P – Partial, F/U – Follow up 
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